Continuing Education Activity

Otitis media with effusion (OME) involves the accumulation of nonpurulent fluid—either mucoid or serous—in the middle ear. This common condition remains a prevalent yet complex condition in pediatric and adult populations, often presenting without acute infection but with significant consequences for hearing and quality of life. Patients frequently report hearing loss and a sensation of fullness in the affected ear without accompanying pain. As fluid collects within the middle ear and the Eustachian tube, pressure builds against the tympanic membrane, impairing its ability to vibrate effectively. This disruption in membrane function diminishes sound conduction, resulting in hearing impairment. This activity provides clinicians with an in-depth review of OME's pathophysiology, risk factors, diagnostic challenges, and evolving treatment strategies, examining the role of Eustachian tube dysfunction, inflammation, anatomical anomalies, and environmental exposures in the development of OME. 

This course explores the various diagnostic modalities—ranging from tympanometry and audiometry to otoacoustic emissions and auditory brainstem responses—utilized to identify and monitor this condition across age groups as well as evidence-based, individualized management strategies, including the appropriate use of pharmacologic agents, watchful waiting, surgical interventions, and hearing support. Clinicians will gain insights into when to refer patients for surgical evaluation and how to assess language development, school performance, and social adaptation when determining the next steps in care. Special considerations for at-risk populations, including children with Down syndrome or cleft palate, will also be explored. This activity for healthcare professionals is designed to enhance the learner's competence in identifying OME, performing the recommended evaluation, and implementing an appropriate interprofessional approach when managing this condition, thereby delivering patient-centered, developmentally sensitive, and outcomes-focused care for individuals with OME.

Objectives:

• Identify the clinical features of otitis media with effusion.
• Apply diagnostic guidelines when evaluating otitis media with effusion.
• Implement tailored treatment strategies for patients with otitis media with effusion.
• Apply interprofessional team strategies to improve care coordination and outcomes in patients with otitis media with effusion.

Introduction

Otitis media encompasses various otologic conditions, including acute otitis media, recurrent acute otitis media, OME, and chronic otitis media.[1] OME is a specific clinical condition characterized only by fluid accumulation in the middle ear without acute infection. The fluid may be either mucoid or serous. Elevated levels of prostaglandins and leukotrienes may be present in middle ear effusions.[2] As fluid accumulates in the middle ear and the Eustachian tube, it exerts pressure on the tympanic membrane. This pressure hinders the tympanic membrane's ability to vibrate correctly, reducing sound conduction and thereby diminishing the patient's hearing.

Most individuals experience no symptoms besides a sensation of fullness in the ear and mild hearing loss. Serous otitis media likely occurs due to the formation of transudate resulting from a rapid decrease in middle ear pressure compared to atmospheric pressure.[3] Mucoid otitis media refers to "glue ear" because of the thick accumulation of mucins, including MUC4, MUC5AC, MUC5B, and MUC6–8.[4] Chronic OME refers to OME that lasts 3 months or longer upon examination or tympanometry. However, some clinicians suggest using the term "chronic otitis media" exclusively for patients who experience complications, including tympanic membrane perforation, mastoiditis, or cholesteatoma.[5] 

Audiometry and tympanometry are the most effective diagnostic tools for OME. Weber and Rinne tests play a minimal role and tend to be subjective. Patient management is customized based on individual needs, particularly in relation to speech and language development risks. Pharmacologic treatments are constrained by both their effectiveness and cost. Myringotomy, with or without the placement of ear ventilation tubes and adenoidectomy, has been effective, whereas tonsillectomy has not proven beneficial. Expectant management is advocated for many patients.[6]

Etiology

OME can arise from several underlying causative factors, including host characteristics, inflammation, infections, allergies, and environmental influences, all of which impact the Eustachian tube and middle ear. The Eustachian tube plays a vital role in balancing air pressure between the middle ear and the external environment, removing secretions, enhancing sound transmission in the middle ear, and protecting both the middle and inner ear. The dominant theory posits that OME develops when negative pressure forms in the middle ear space.[7] This negative pressure triggers a transudate from the mucosa, resulting in a sterile effusion. This fluid may create an environment conducive to infection. However, this theory may have limitations, as identical pathogenic bacteria have been identified in acute OME.[8]

Host Factors

Contributing host factors to the evolution of OME include:

• Physiological dysfunction of the Eustachian tube [9]

  • Anatomic blockage
  • Inflammation

    • Allergies
    • Upper respiratory tract infection
    • Trauma
• Immune system

  • Immature
  • Impaired with congenital immune deficiencies, HIV, diabetes, or other developmental anomalies [10]
• Genetic predisposition
• Mucins
• Anatomic abnormalities including cleft palate, Crouzon or Apert syndrome, and Treacher Collins syndrome [11]

  • Children with developmental anomalies affecting the palate, palate muscles, and muscle tone, or variations in bone development, are at a higher risk of developing OME, eg, cleft palate and Down syndrome.[12] 
  • Patients with Down syndrome may experience disorders of mucociliary function that further increase the risk of developing OME.[13][14]
• Age

  • The eustachian tube is positioned more horizontally in younger children than at a 45-degree angle in adults. As the child develops into an adult, the tube elongates and angles caudally. 
  • The size and shape of the Eustachian tube at birth are unfavorable for the ventilation of the middle ear.
  • The peak incidence of OME occurs in children aged 2 to 4 years.[15]
  • Adults with unilateral OME must be evaluated for a nasopharyngeal mass.[16]

Environmental Factors 

Environmental factors that increase the risk of developing OME include:

• Having a sibling with otitis media
• Attending daycare [13] 
• Having allergies to common environmental substances
• Lower socioeconomic status [17]
• Second-hand or third-hand smoke [18]
• Parental history of OME
• Dietary factors

  • Bottle feeding
  • Feeding while supine
  • A high-fat diet is a risk factor for OME [19]
  • Obesity may be a confounding factor [20]
•  Ethnicity

  • Children of Asian ethnicity may show a lower incidence of OME [21]
• Gastroesophageal reflux (adults) [22][23]

Both children and adults may develop OME, though the underlying causes differ between these groups. In younger children, the Eustachian tube lies in a more horizontal orientation. As the child develops into an adult, the tube elongates and shifts to a more caudal angle. This anatomical progression explains the higher incidence of OME in children. Additionally, head positioning during early childhood plays a significant role in the development of the condition.[12]

Epidemiology

OME ranks as the most common disease affecting children.[24] As the leading cause of acquired hearing loss in childhood, OME often develops early in life.[25] By age 4, up to 80% of children experience at least 1 episode, though prevalence typically declines after the age of 6 years.[26] Most children recover within 3 months without intervention; however, recurrence occurs in approximately 30% to 40% of cases.[27]

OME can adversely affect developmental milestones, particularly during the first year of life, and may significantly impact the quality of life for both children and their parents, contributing to physical, emotional, and financial stress.[28][29][28] The highest prevalence is observed in children younger than 2, followed by a marked decline after the age of 5 years.[30] Incidence rates rise during the winter months, correlating with an increase in upper respiratory infections, especially among children from lower socioeconomic backgrounds.[31]

Pathophysiology

OME, or "glue ear," involves fluid accumulation in the middle ear, with viscosity ranging from thin and serous to thick and mucoid. The primary theories explaining its pathophysiology include inflammatory mechanisms, biofilms, gastroesophageal reflux, and the structure of the eustachian tube (see Image. Acute Otitis Media Pathophysiology).

Inflammatory Hypothesis

Inflammation and immune responses to rhinopharyngeal infections contribute to OME. Although previously believed to involve sterile effusion, polymerase chain reaction (PCR) assays have identified bacterial RNA and DNA in middle ear fluid.[32] Pathogens such as Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis have been visualized using confocal microscopy.[33]

Biofilms

Biofilms, consisting of adherent bacterial communities embedded in a matrix of polysaccharides, nucleic acids, and proteins, have been detected in over half of culture-negative OME cases.[34] These bacteria, often metabolically active, survive in low-oxygen environments and show resistance to systemic antibiotics.[35][36][35]

Gastroesophageal Reflux and Allergy

Pepsins and Helicobacter pylori have been identified in middle ear effusions, suggesting a link to Gastroesophageal reflux.[37][38] Children with chronic rhinitis, turbinate hypertrophy, asthma, or allergies may face an elevated risk.[39] Mucin gene activation may also contribute, with membrane-bound proteins, eg, MUC1, MUC3, and MUC4 facilitating microbial attachment, while MUC5AC and MUC5B promote mucus accumulation in the middle ear.[40][41]

Eustachian Tube Structure

In children, the Eustachian tube's shorter, more horizontal orientation and limited closure capacity reduce its ability to regulate pressure and prevent contamination of the middle ear space. Enlarged adenoids may further obstruct the Eustachian tube, exacerbating the condition.[42]

Histopathology

Researchers believe the mucociliary defense system in the Eustachian tube is the first line of defense in the middle ear. This system relies on immunoglobulins produced by the mucosa. Since these immunoglobulins are significantly elevated in effusions, the defense system may be overactive in OME.[43] Additionally, hyperplasia of the middle ear is a key part of OME and may be linked to the expression of the heparin-binding epidermal growth factor (HB-EGF).[44] Histopathology of the temporal bone in OME reveals mucosal inflammation and metaplasia, accompanied by edema, vascular dilation, hyperplasia, and infiltration by mononuclear cells, similar to that seen in acute otitis media.[45]

Toxicokinetics

In addition to bacterial pathogens, OME may also be caused by inflammation driven by viruses or allergies. While allergy is a significant risk factor for otitis media, clinical practice guidelines (2004) concluded that there was little evidence to support specific management strategies for allergy-induced OME.[46] However, treatment of allergic rhinitis may assist patients who develop OME in conjunction with allergies.[47] Some recommend screening children with allergies or asthma for OME.[39] Other experts recommend screening for allergies only when OME is paired with asthma or chronic rhinitis.[48] 

History and Physical

Clinical Features

Hearing loss, though not always readily apparent, represents the most frequently reported symptom of OME by patients, families, or caregivers. OME commonly results in communication difficulties, delayed language development, academic struggles, behavioral or sleep disturbances, social withdrawal, and reduced concentration during activities, eg, conversations, listening to music, or watching television.

Many children present with a history of prior ear infections or hearing changes. Complaints may include a sensation of blocked ears, popping sounds, ear pain, or frequent ear tugging. Most children experience an episode of acute otitis media—characterized by fever, pain, and upper respiratory symptoms—before developing OME. In adults, OME typically presents unilaterally and often follows upper respiratory symptoms. Adult patients may report hearing loss, tinnitus, or a sensation of fullness or obstruction in the ear canal. Middle ear fluid accumulation in adults often occurs after pressure changes, such as during flying or diving.

A thorough medical history should include previous ear infections, hearing loss, tinnitus, vertigo, ear drainage, or prior procedures such as tympanostomy tube placement, tonsillectomy, or adenoidectomy. Pneumatic otoscopy remains essential for evaluating the ear canal and eardrum, including assessment of tympanic membrane mobility and light reflex (see Image. Acute Otitis Media on Otoscopy). When available, binocular microscopes or video-otoscopes provide additional diagnostic support. In some cases, air bubbles, a liquid film, cloudiness, or bluish or yellowish discoloration of the tympanic membrane may be visible.

Evaluation

Audiometry and Tympanometry Evaluation

Age-appropriate pure-tone audiometry and tympanometry should be performed to assess hearing. A "flat" tympanogram will support a diagnosis of OME.[49] Testing hearing in infants can be done using auditory brainstem responses (ABR) or brainstem auditory evoked potentials (BAEP). These tests assess the functioning of the auditory pathway, from the auditory nerve to the brainstem. ABR is considered the gold standard for confirming hearing loss in infants who fail newborn screenings; however, it doesn't specifically detect conductive hearing loss resulting from middle ear effusion. Another option is otoacoustic emissions (OAE), which can be used for hearing screening. However, OAE is not very specific and may be inaccurate if background sounds are present.

The 3 types of hearing loss are sensorineural (SNHL), conductive, and mixed hearing loss.[50] OME can lead to conductive hearing loss by impacting the transmission of sound from the air through the middle ear structures. This condition may create an air-bone gap >15 dB HL. In some children, mixed hearing loss may be present, as SNHL is known to occur in otitis media, although the etiology is not yet understood. Children with suspected OME should undergo language testing to assess for language delay.

Additional Diagnostic Studies

Other tests that have been used include:

• Erythrocyte sedimentation rate (ESR) to rule out bone destruction (rarely used)
• Complete blood count (CBC) for ruling out acute infection
• Computed tomography scan to rule out middle ear disease, eg, cholesteatoma, extracranial or intracranial abnormalities, or congenital anomalies
• Magnetic resonance imaging scan for soft tissue masses or intracranial abnormalities

Tympanocentesis has been recommended in certain clinical contexts. This procedure, typically conducted in an office setting, may serve both diagnostic (culture) and therapeutic purposes.[51] However, most otolaryngologists prefer myringotomy for improved visualization, middle ear drainage, and placement of ear ventilation tubes in uncomplicated OME patients.

Treatment / Management

Expectant Management

OME may resolve on its own, or the hearing loss may be minor, making watchful waiting an option. Modification of risk factors during ongoing expectant management may be beneficial, including:

• Avoidance of known allergens
• Avoidance of feeding, either breast or bottle, while the child is supine
• Breastfeeding when possible
• Avoidance of secondhand or thirdhand smoke
• Avoidance of daycare settings or places where children may have upper respiratory infections
• Chewing gum at least once a week (a study showed a 40% reduction in OME) [52]

Autoinsufflation

Autoinsufflation involves forcing air from the nose and throat into the middle ear to equalize pressure and promote drainage. This technique proves especially helpful for adults capable of performing the maneuver independently. Children who understand and can execute autoinsufflation may also benefit, as the practice can help clear middle ear effusions, enhance hearing, and improve overall quality of life.[53]

Pharmacological Management

Pharmacologic management of OME includes:

• Antibiotics (eg, erythromycin, sulfisoxazole, amoxicillin, amoxicillin-clavulanate, and trimethoprim-sulfamethoxazole)

  • May be of only short-term benefit [54]
  • Most studies indicate that the benefits of antibiotics for clearing middle ear effusion are transient, with rapid and frequent recurrence, despite nearly one-third of children with OME being prescribed oral antibiotics in emergency settings.[55]
• Steroids with or without antibiotics

  • No statistically significant impact on hearing improvement from the use of oral steroids after OME persists for 3 to 9 months. However, a slight improvement is noted at 12 months of OME persistence with the use of oral steroids.[56]
  • Topical intranasal steroids, alone or in combination with oral antibiotics, have no statistically significant benefit [57][58]
• Antihistamines, decongestants, or mucolytics

  • No statistically significant benefit of antihistamines, decongestants, or mucolytics.[26][59]
  • May only relieve associated upper respiratory symptoms such as nasal obstruction, rhinorrhea, or cough.
  • Antihistamines may worsen OME by increasing the viscosity of the middle ear fluid [60]

Surgical Management

Surical therapies are widely accepted and effective, but the indications remain controversial. Interventions include:

Myringotomy with tympanostomy tube insertion

Myringotomy with tympanostomy tube insertion serves as an effective treatment for OME.[61] Ventilation tubes enable air entry into the middle ear, reducing the likelihood of fluid reaccumulation. Following the procedure, many patients require no further therapy, as the natural growth and angulation of the Eustachian tube support improved drainage. Extended middle ear ventilation helps reverse mucosal hyperplasia and metaplasia. Pressure equalization tubes come in various configurations, materials, and designs.

Complications occur in approximately 10% of cases and may include persistent otorrhea, tympanosclerosis, or tympanic membrane perforation. Less common complications include granulation tissue formation, cholesteatoma, and sensorineural hearing loss.[62] A hearing loss threshold of 40 dB or greater often prompts surgical consideration, although decisions also depend on factors, eg, speech and language development.

In children, most procedures are performed under general anesthesia without the need for intubation. Newer techniques, including single-pass devices, are being evaluated for use in office-based settings. In adults, unilateral procedures are more common and typically conducted in-office with local anesthesia.[63] While most adults tolerate the procedure well, some may experience intermittent or chronic ear discharge.[64]

Myringotomy and aspiration of fluid without tympanostomy tube placement

Myringotomy with fluid aspiration alone generally offers less benefit without tympanostomy tube insertion, though select adult patients may experience immediate relief.

Adenoidectomy and tonsillectomy

Tonsillectomy does not improve outcomes for patients with OME. In contrast, adenoidectomy—with or without concurrent tympanostomy tube placement—plays a key role in managing persistent or recurrent OME.[65] Many otolaryngologists recommend both procedures when ventilation tubes alone fail to prevent recurrence. Adenoid size alone does not reliably predict surgical success. Adenoidectomy may help by reducing nasopharyngeal pressure during swallowing, limiting Eustachian tube reflux, relieving functional obstruction at the Eustachian tube orifice, and eliminating a potential source of chronic inflammation or infection.[66][67][68]

Hearing Aids or other assistive hearing devices (limited use in OME)

Hearing aids and other assistive listening devices have limited use in the management of OME. Childhood hearing loss can negatively influence language development.[69] Hearing aids offer a noninvasive treatment option for OME; yet, most children with this condition do not receive referrals to audiology for hearing aids or assistive devices.[70] While hearing aids may provide significant benefits, some children experience adverse effects such as self-consciousness or teasing, which can reduce device usage and limit effectiveness.[71] Among those referred for hearing aids due to OME-related hearing loss, only about half are eventually fitted with a device.[70]

An individualized, patient-focused approach should be adopted.[72][73][74] How the child is coping socially and at school may be more important than the results of audiometry investigations when deciding whether to proceed with surgery.[75][76][77] However, certain otologic findings may prompt surgical intervention, eg, the formation of a posterior superior retraction pocket, ossicular abnormalities or erosions, adhesive atelectasis, and keratin debris in the ear canal. 

Differential Diagnosis

Adults

Differential diagnoses that should be considered when evaluating OME in adults include:

• Benign nasopharyngeal masses
• Acute otitis media
• Myringitis
• Patulous Eustachian tube
• Malignant tumors of the nasal cavity
• Malignant tumors of the temporal bone
• Nasopharyngeal carcinoma [16]

Children

Differential diagnoses that should be considered when evaluating OME in children include:

• Acute otitis media [46]
• Myringitis
• Adenoid hypertrophy
• Congenital craniofacial anomalies

  • Down syndrome
  • Cleft palate
  • Achondroplasia
  • Treacher Collins syndrome
  • Hemifacial microsomia
  • CHARGE syndrome
  • Klippel-Feil syndrome
• Ciliary dyskinesia
• Cystic fibrosis
• Immunoglobulin G (IgG) subclass deficiencies

Prognosis

In 2016, the American Academy of Otolaryngology-Head and Neck Surgery Foundation (AAO-HNS), with the endorsement of the American Academy of Family Physicians (AAFP), updated its clinical practice guidelines for the diagnosis and management of OME.[78] For OME, the prognosis is generally good. Treatment is tailored to each patient, focusing on their individual needs. In most cases, children with OME will recover from hearing loss and speech and language delays, with no lasting effects. Adults with OME also tend to have a positive outlook, depending on the underlying condition. Malignancies related to OME remain rare.

Complications

The vast majority of patients with OME see a resolution of their signs and symptoms with appropriate management and follow-up. Complications are generally rare, but may depend on an underlying condition or comorbidity.

Minor complications associated with OME include:

• Hearing loss (conductive, sensorineural, or mixed) [79]
• Tympanic membrane perforation [80]
• Tympanosclerosis [81]
• Acute or chronic suppurative otitis media [82]
• Speech and language delay [83]

Major complications of OME, which are rarer, include:

• Cholesteatoma
• Postauricular abscess
• Mastoiditis
• Labyrinthitis
• Facial nerve paresis or paralysis
• Temporal bone abscess
• Petrositis
• Intracranial abscess
• Meningitis
• Otitic hydrocephalus
• Sigmoid sinus thrombosis
• Encephalocele
• Cerebrospinal fluid leak
• Nasal or nasopharyngeal complications related to the underlying condition

Postoperative and Rehabilitation Care

Most children who undergo myringotomy and ear ventilation tube placement or adenoidectomy to treat OME require minimal postoperative care. These procedures are performed on an outpatient basis with few complications or long-term sequelae. Rehabilitation may include speech and language training once the child's hearing has improved. Repeat pure tone audiometry may be necessary for monitoring.

Adults who undergo myringotomy and ear ventilation tube placement typically experience immediate improvement. This procedure is conducted in an office setting under binocular microscopy, resulting in minimal discomfort. Follow-up and management depend on diagnosing and treating any underlying medical conditions.

Most otolaryngologists recommend using otic drops after a myringotomy and ear tube placement to prevent infections and ensure the tube's proper function and patency. These ear drops can also help manage postoperative otorrhea. However, some ambiguity regarding which type of antibiotic drops surgeons use exists due to concerns about potential ototoxicity.[84] Many surgeons avoid drops containing aminoglycosides, eg, gentamicin or neomycin, but the choice of medication often relies on the surgeon's experience and personal preference.

Consultations

Consultations may involve a wide range of medical professionals, including pediatricians, neonatal specialists, geneticists, family doctors, internal medicine specialists, neurologists, pulmonologists, cardiologists, audiologists, allergists, speech therapists, and otolaryngologists.

Deterrence and Patient Education

Evaluating, diagnosing, and managing OME should involve a collaborative effort among patients, families, educators, and healthcare professionals. Hearing difficulties can lead to behavioral issues, reduced educational or training opportunities, balance problems, and various other medical complications. Patient education must be tailored to individual needs, with thorough follow-up that includes pneumatic otoscopy, tympanometry, and pure-tone audiometry.

Children with suspected craniofacial anomalies or congenital disorders require careful attention and evaluation. Adults with unilateral OME should undergo a comprehensive evaluation, including nasopharyngoscopy, to identify underlying causes, eg, nasal or nasopharyngeal lesions and infections. Clinicians should have a low threshold for obtaining imaging in patients suspected of having upper airway abnormalities, which may underlie OME. The use of antibiotics, steroids, antihistamines, leukotriene receptor antagonists, mucolytics, proton pump inhibitors, anti-reflux medications, and decongestants in treating OME should be avoided.[85] 

Pearls and Other Issues

The following factors should be kept in mind when managing OME:

• Pneumatic otoscopy should be used to document the presence of middle ear effusion in patients with otalgia, hearing loss, or tinnitus.
• Pure-tone audiometry and tympanometry should be obtained, if available, and the patient is cooperative.
• Weber and Rinne tests tend to be subjective and of less value than pure-tone audiometry and tympanometry.
• For most children diagnosed with OME, conservative treatment with watchful waiting is recommended within the first 3 months of diagnosis.
• Hearing aids or other assistive devices play a limited role in OME management. They should be discouraged in adults with unilateral OME who have not undergone a thorough evaluation by an otolaryngologist and audiologist.
• Antibiotics, steroids, or other medications should be avoided in most patients, particularly without comorbidities.
• Management should focus on elective myringotomy, ear ventilation tube placement, or adenoidectomy.
• Adults with unilateral OME should undergo a thorough head and neck examination, including nasopharyngoscopy, and imaging as appropriate to rule out malignancy or other abnormalities, such as nasal polyps and chronic sinusitis.
• Children with persistent OME should be evaluated for craniofacial anomalies, congenital disorders, or other systemic etiologies.
• Caution should be used in patients with a suspicion on otoscopy of posterior superior retraction pockets, cholesteatoma, or other otologic abnormalities.

Enhancing Healthcare Team Outcomes

Delivering patient-centered care for individuals with OME depends on the coordinated efforts of an interprofessional healthcare team. Physicians, advanced practice practitioners, audiologists, speech therapists, and other specialists must apply clinical expertise to ensure accurate diagnosis and effective management. A high level of skill is required to distinguish OME from other middle ear conditions and to avoid unnecessary pharmacologic interventions. Particular attention must be paid to the developmental impact of hearing loss in young children, including the risks it poses to speech and language acquisition. Adult patients also require thorough evaluation to rule out nasopharyngeal masses or other structural abnormalities. A strategic, evidence-based approach should guide decision-making, incorporating each patient’s medical history, developmental stage, family context, and social environment. Individualized care plans must address not only clinical needs but also educational and psychosocial factors, especially when evaluating surgical interventions such as tympanostomy tube placement or adenoidectomy.

Interprofessional collaboration plays a vital role in improving outcomes and ensuring patient safety. Clearly defined responsibilities among team members allow each professional to contribute effectively—physicians lead diagnostic and treatment efforts, nurses support patient education and monitoring, audiologists assess hearing function, and speech therapists address communication delays. Pharmacists contribute by evaluating medication use and preventing the use of ineffective treatments. Open, respectful communication among disciplines fosters timely information exchange, encourages clinical inquiry, and enhances shared decision-making. Coordinated care pathways, from initial evaluation through treatment and follow-up, reduce fragmentation, prevent delays in care, and minimize diagnostic and therapeutic errors. These efforts not only support optimal hearing and developmental outcomes but also improve patient satisfaction, reduce the burden on families, and strengthen the overall performance of the healthcare team.

Review Questions

• Access free multiple choice questions on this topic.
• Click here for a simplified version.
• Comment on this article.

References

1.

Morris PS, Leach AJ. Acute and chronic otitis media. Pediatr Clin North Am. 2009 Dec;56(6):1383-99. [PMC free article: PMC7111681] [PubMed: 19962027]

2.

Jung TT. Prostaglandins, leukotrienes, and other arachidonic acid metabolites in the pathogenesis of otitis media. Laryngoscope. 1988 Sep;98(9):980-93. [PubMed: 2842558]

3.

O'Connor SS, Coggins R, Gagnon L, Rosenfeld RM, Shin JJ, Walsh SA. Plain Language Summary: Otitis Media with Effusion. Otolaryngol Head Neck Surg. 2016 Feb;154(2):215-25. [PubMed: 26833646]

4.

Lin J, Tsuboi Y, Rimell F, Liu G, Toyama K, Kawano H, Paparella MM, Ho SB. Expression of mucins in mucoid otitis media. J Assoc Res Otolaryngol. 2003 Sep;4(3):384-93. [PMC free article: PMC3202728] [PubMed: 14690056]

5.

Emmett SD, Kokesh J, Kaylie D. Chronic Ear Disease. Med Clin North Am. 2018 Nov;102(6):1063-1079. [PubMed: 30342609]

6.

MacKeith S, Mulvaney CA, Galbraith K, Webster KE, Paing A, Connolly R, Marom T, Daniel M, Venekamp RP, Schilder AG. Adenoidectomy for otitis media with effusion (OME) in children. Cochrane Database Syst Rev. 2023 Oct 23;10(10):CD015252. [PMC free article: PMC10591285] [PubMed: 37870083]

7.

Ars B, Dirckx J. Eustachian Tube Function. Otolaryngol Clin North Am. 2016 Oct;49(5):1121-33. [PubMed: 27468632]

8.

Korona-Glowniak I, Wisniewska A, Juda M, Kielbik K, Niedzielska G, Malm A. Bacterial aetiology of chronic otitis media with effusion in children - risk factors. J Otolaryngol Head Neck Surg. 2020 Apr 29;49(1):24. [PMC free article: PMC7191732] [PubMed: 32349795]

9.

Bluestone CD. Eustachian tube function: physiology, pathophysiology, and role of allergy in pathogenesis of otitis media. J Allergy Clin Immunol. 1983 Sep;72(3):242-51. [PubMed: 6886258]

10.

Raje N, Dinakar C. Overview of Immunodeficiency Disorders. Immunol Allergy Clin North Am. 2015 Nov;35(4):599-623. [PMC free article: PMC4600970] [PubMed: 26454309]

11.

Akintoye SO, Adisa AO, Okwuosa CU, Mupparapu M. Craniofacial disorders and dysplasias: Molecular, clinical, and management perspectives. Bone Rep. 2024 Mar;20:101747. [PMC free article: PMC10985038] [PubMed: 38566929]

12.

Nemade SV, Shinde KJ, Rangankar VP, Bhole P. Evaluation and significance of Eustachian tube angles and pretympanic diameter in HRCT temporal bone of patients with chronic otitis media. World J Otorhinolaryngol Head Neck Surg. 2018 Dec;4(4):240-245. [PMC free article: PMC6284192] [PubMed: 30564785]

13.

Zernotti ME, Pawankar R, Ansotegui I, Badellino H, Croce JS, Hossny E, Ebisawa M, Rosario N, Sanchez Borges M, Zhang Y, Zhang L. Otitis media with effusion and atopy: is there a causal relationship? World Allergy Organ J. 2017;10(1):37. [PMC free article: PMC5684754] [PubMed: 29158869]

14.

Kucur C, Şimşek E, Kuduban O, Özbay İ. Prevalence of and risk factors for otitis media with effusion in primary school children: case control study in Erzurum, Turkey. Turk J Pediatr. 2015 May-Jun;57(3):230-5. [PubMed: 26701940]

15.

Riaz N, Ajmal M, Khan MS. Frequency of otitis media with effusion among children aged 1-5 years presenting to immunization center of tertiary care hospitals, Rawalpindi. World J Otorhinolaryngol Head Neck Surg. 2022 Dec;8(4):315-320. [PMC free article: PMC9714043] [PubMed: 36474664]

16.

Mills R, Hathorn I. Aetiology and pathology of otitis media with effusion in adult life. J Laryngol Otol. 2016 May;130(5):418-24. [PubMed: 26976514]

17.

Siddartha, Bhat V, Bhandary SK, Shenoy V, Rashmi Otitis media with effusion in relation to socio economic status: a community based study. Indian J Otolaryngol Head Neck Surg. 2012 Mar;64(1):56-8. [PMC free article: PMC3244594] [PubMed: 23449688]

18.

Erdivanli OC, Coskun ZO, Kazikdas KC, Demirci M. Prevalence of Otitis Media with Effusion among Primary School Children in Eastern Black Sea, in Turkey and the Effect of Smoking in the Development of Otitis Media with Effusion. Indian J Otolaryngol Head Neck Surg. 2012 Mar;64(1):17-21. [PMC free article: PMC3244593] [PubMed: 23449553]

19.

Choi HG, Sim S, Kim SY, Lee HJ. A high-fat diet is associated with otitis media with effusion. Int J Pediatr Otorhinolaryngol. 2015 Dec;79(12):2327-31. [PubMed: 26553398]

20.

Kaya S, Selimoğlu E, Cureoğlu S, Selimoğlu MA. Relationship between chronic otitis media with effusion and overweight or obesity in children. J Laryngol Otol. 2017 Oct;131(10):866-870. [PubMed: 28807075]

21.

Walker RE, Bartley J, Flint D, Thompson JM, Mitchell EA. Determinants of chronic otitis media with effusion in preschool children: a case-control study. BMC Pediatr. 2017 Jan 06;17(1):4. [PMC free article: PMC5217332] [PubMed: 28056905]

22.

Yeo CD, Kim JS, Lee EJ. Association of gastroesophageal reflux disease with increased risk of chronic otitis media with effusion in adults: A nationwide population-based cohort study. Medicine (Baltimore). 2021 Aug 20;100(33):e26940. [PMC free article: PMC8376319] [PubMed: 34414952]

23.

Yeo CD, Kim JS, Lee EJ. Association of gastroesophageal reflux disease with increased risk of chronic otitis media with effusion in adults: A nationwide population-based cohort study. Medicine (Baltimore). 2021 Jul 23;100(29):e26727. [PMC free article: PMC8294894] [PubMed: 34398048]

24.

Albazah NIJ, Loh HM, Lee JY, Chen WK, Khaw EYJ, Ngu PK, Elhariri SYZ. Critical appraisal of clinical practice guidelines for otitis media in Asian and Western countries with consideration of updates: A narrative review. Malays Fam Physician. 2024;19:67. [PMC free article: PMC11627169] [PubMed: 39654866]

25.

Coleman A, Cervin A. Probiotics in the treatment of otitis media. The past, the present and the future. Int J Pediatr Otorhinolaryngol. 2019 Jan;116:135-140. [PubMed: 30554684]

26.

Williamson I. Otitis media with effusion in children. BMJ Clin Evid. 2007 Aug 01;2007 [PMC free article: PMC2943809] [PubMed: 19454116]

27.

Ito M, Takahashi H, Iino Y, Kojima H, Hashimoto S, Kamide Y, Kudo F, Kobayashi H, Kuroki H, Nakano A, Hidaka H, Takahashi G, Yoshida H, Nakayama T. Clinical practice guidelines for the diagnosis and management of otitis media with effusion (OME) in children in Japan, 2015. Auris Nasus Larynx. 2017 Oct;44(5):501-508. [PubMed: 28473270]

28.

Zulkiflee S, Siti Sabzah M, Philip R, Mohd Aminuddin M. Management of otitis media with effusion in children. Malays Fam Physician. 2013;8(2):32-5. [PMC free article: PMC4170480] [PubMed: 25606279]

29.

Crawford B, Hashim SS, Prepageran N, See GB, Meier G, Wada K, Coon C, Delgleize E, DeRosa M. Impact of Pediatric Acute Otitis Media on Child and Parental Quality of Life and Associated Productivity Loss in Malaysia: A Prospective Observational Study. Drugs Real World Outcomes. 2017 Mar;4(1):21-31. [PMC free article: PMC5332310] [PubMed: 27888477]

30.

Humaid AH, Ashraf AH, Masood KA, Nuha AH, Saleh AD, Awadh AM. Prevalence and risk factors of Otitis Media with effusion in school children in Qassim Region of Saudi Arabia. Int J Health Sci (Qassim). 2014 Oct;8(4):325-34. [PMC free article: PMC4350887] [PubMed: 25780352]

31.

Castagno LA, Lavinsky L. Otitis media in children: seasonal changes and socioeconomic level. Int J Pediatr Otorhinolaryngol. 2002 Feb 01;62(2):129-34. [PubMed: 11788145]

32.

Fergie N, Bayston R, Pearson JP, Birchall JP. Is otitis media with effusion a biofilm infection? Clin Otolaryngol Allied Sci. 2004 Feb;29(1):38-46. [PubMed: 14961850]

33.

Hall-Stoodley L, Hu FZ, Gieseke A, Nistico L, Nguyen D, Hayes J, Forbes M, Greenberg DP, Dice B, Burrows A, Wackym PA, Stoodley P, Post JC, Ehrlich GD, Kerschner JE. Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media. JAMA. 2006 Jul 12;296(2):202-11. [PMC free article: PMC1885379] [PubMed: 16835426]

34.

Palmer JN. Bacterial biofilms: do they play a role in chronic sinusitis? Otolaryngol Clin North Am. 2005 Dec;38(6):1193-201, viii. [PubMed: 16326178]

35.

Van Hoecke H, De Paepe AS, Lambert E, Van Belleghem JD, Cools P, Van Simaey L, Deschaght P, Vaneechoutte M, Dhooge I. Haemophilus influenzae biofilm formation in chronic otitis media with effusion. Eur Arch Otorhinolaryngol. 2016 Nov;273(11):3553-3560. [PubMed: 26946303]

36.

Belfield K, Bayston R, Birchall JP, Daniel M. Do orally administered antibiotics reach concentrations in the middle ear sufficient to eradicate planktonic and biofilm bacteria? A review. Int J Pediatr Otorhinolaryngol. 2015 Mar;79(3):296-300. [PubMed: 25623134]

37.

Formánek M, Zeleník K, Komínek P, Matoušek P. Diagnosis of extraesophageal reflux in children with chronic otitis media with effusion using Peptest. Int J Pediatr Otorhinolaryngol. 2015 May;79(5):677-9. [PubMed: 25736547]

38.

Doğru M, Kuran G, Haytoğlu S, Dengiz R, Arıkan OK. Role of Laryngopharyngeal Reflux in the Pathogenesis of Otitis Media with Effusion. J Int Adv Otol. 2015 Apr;11(1):66-71. [PubMed: 26223722]

39.

Mold JW, Fox C, Wisniewski A, Lipman PD, Krauss MR, Harris DR, Aspy C, Cohen RA, Elward K, Frame P, Yawn BP, Solberg LI, Gonin R. Implementing asthma guidelines using practice facilitation and local learning collaboratives: a randomized controlled trial. Ann Fam Med. 2014 May-Jun;12(3):233-40. [PMC free article: PMC4018371] [PubMed: 24821894]

40.

Kubba H, Pearson JP, Birchall JP. The aetiology of otitis media with effusion: a review. Clin Otolaryngol Allied Sci. 2000 Jun;25(3):181-94. [PubMed: 10944048]

41.

Vanneste P, Page C. Otitis media with effusion in children: Pathophysiology, diagnosis, and treatment. A review. J Otol. 2019 Jun;14(2):33-39. [PMC free article: PMC6570640] [PubMed: 31223299]

42.

Bluestone CD, Cantekin EI, Beery QC. Certain effects of adenoidectomy of Eustachian tube ventilatory function. Laryngoscope. 1975 Jan;85(1):113-27. [PubMed: 1089852]

43.

Lim DJ. Functional morphology of the mucosa of the middle ear and Eustachian tube. Ann Otol Rhinol Laryngol. 1976 Mar-Apr;85(2 Suppl 25 Pt 2):36-43. [PubMed: 1267366]

44.

Sakamoto T, Pak K, Chavez E, Ryan AF, Kurabi A. HB-EGF Plays a Pivotal Role in Mucosal Hyperplasia During Otitis Media Induced by a Viral Analog. Front Cell Infect Microbiol. 2022;12:823714. [PMC free article: PMC8904902] [PubMed: 35281434]

45.

Magliocca KR, Vivas EX, Griffith CC. Idiopathic, Infectious and Reactive Lesions of the Ear and Temporal Bone. Head Neck Pathol. 2018 Sep;12(3):328-349. [PMC free article: PMC6081288] [PubMed: 30069844]

46.

Rosenfeld RM, Culpepper L, Doyle KJ, Grundfast KM, Hoberman A, Kenna MA, Lieberthal AS, Mahoney M, Wahl RA, Woods CR, Yawn B., American Academy of Pediatrics Subcommittee on Otitis Media with Effusion. American Academy of Family Physicians. American Academy of Otolaryngology--Head and Neck Surgery. Clinical practice guideline: Otitis media with effusion. Otolaryngol Head Neck Surg. 2004 May;130(5 Suppl):S95-118. [PubMed: 15138413]

47.

Skoner AR, Skoner KR, Skoner DP. Allergic rhinitis, histamine, and otitis media. Allergy Asthma Proc. 2009 Sep-Oct;30(5):470-81. [PubMed: 19843400]

48.

Seidman MD, Gurgel RK, Lin SY, Schwartz SR, Baroody FM, Bonner JR, Dawson DE, Dykewicz MS, Hackell JM, Han JK, Ishman SL, Krouse HJ, Malekzadeh S, Mims JW, Omole FS, Reddy WD, Wallace DV, Walsh SA, Warren BE, Wilson MN, Nnacheta LC., Guideline Otolaryngology Development Group. AAO-HNSF. Clinical practice guideline: Allergic rhinitis. Otolaryngol Head Neck Surg. 2015 Feb;152(1 Suppl):S1-43. [PubMed: 25644617]

49.

Cai T, McPherson B, Li C, Yang F. Pure tone hearing profiles in children with otitis media with effusion. Disabil Rehabil. 2018 May;40(10):1166-1175. [PubMed: 28637148]

50.

Cunningham LL, Tucci DL. Hearing Loss in Adults. N Engl J Med. 2017 Dec 21;377(25):2465-2473. [PMC free article: PMC6457651] [PubMed: 29262274]

51.

Pichichero ME, Poole MD. Assessing diagnostic accuracy and tympanocentesis skills in the management of otitis media. Arch Pediatr Adolesc Med. 2001 Oct;155(10):1137-42. [PubMed: 11576009]

52.

Kouwen HB, DeJonckere PH. Prevalence of OME is reduced in young children using chewing gum. Ear Hear. 2007 Aug;28(4):451-5. [PubMed: 17609608]

53.

Williamson I, Vennik J, Harnden A, Voysey M, Perera R, Kelly S, Yao G, Raftery J, Mant D, Little P. Effect of nasal balloon autoinflation in children with otitis media with effusion in primary care: an open randomized controlled trial. CMAJ. 2015 Sep 22;187(13):961-969. [PMC free article: PMC4577342] [PubMed: 26216608]

54.

Williams RL, Chalmers TC, Stange KC, Chalmers FT, Bowlin SJ. Use of antibiotics in preventing recurrent acute otitis media and in treating otitis media with effusion. A meta-analytic attempt to resolve the brouhaha. JAMA. 1993 Sep 15;270(11):1344-51. [PubMed: 8141875]

55.

Roditi RE, Liu CC, Bellmunt AM, Rosenfeld RM, Shin JJ. Oral Antibiotic Use for Otitis Media with Effusion: Ongoing Opportunities for Quality Improvement. Otolaryngol Head Neck Surg. 2016 May;154(5):797-803. [PubMed: 26932973]

56.

Mulvaney CA, Galbraith K, Webster KE, Rana M, Connolly R, Tudor-Green B, Marom T, Daniel M, Venekamp RP, Schilder AG, MacKeith S. Topical and oral steroids for otitis media with effusion (OME) in children. Cochrane Database Syst Rev. 2023 Dec 13;12(12):CD015255. [PMC free article: PMC10718197] [PubMed: 38088821]

57.

Simpson SA, Lewis R, van der Voort J, Butler CC. Oral or topical nasal steroids for hearing loss associated with otitis media with effusion in children. Cochrane Database Syst Rev. 2011 May 11;2011(5):CD001935. [PMC free article: PMC9829244] [PubMed: 21563132]

58.

Williamson I, Benge S, Barton S, Petrou S, Letley L, Fasey N, Abangma G, Dakin H, Little P. A double-blind randomised placebo-controlled trial of topical intranasal corticosteroids in 4- to 11-year-old children with persistent bilateral otitis media with effusion in primary care. Health Technol Assess. 2009 Aug;13(37):1-144. [PubMed: 19671372]

59.

Cantekin EI, Mandel EM, Bluestone CD, Rockette HE, Paradise JL, Stool SE, Fria TJ, Rogers KD. Lack of efficacy of a decongestant-antihistamine combination for otitis media with effusion ("secretory" otitis media) in children. Results of a double-blind, randomized trial. N Engl J Med. 1983 Feb 10;308(6):297-301. [PubMed: 6337322]

60.

Griffin G, Flynn CA. Antihistamines and/or decongestants for otitis media with effusion (OME) in children. Cochrane Database Syst Rev. 2011 Sep 07;2011(9):CD003423. [PMC free article: PMC7170417] [PubMed: 21901683]

61.

Teschner M. Evidence and evidence gaps in the treatment of Eustachian tube dysfunction and otitis media. GMS Curr Top Otorhinolaryngol Head Neck Surg. 2016;15:Doc05. [PMC free article: PMC5169078] [PubMed: 28025605]

62.

Burton MJ, Rosenfeld RM. Grommets (ventilation tubes) for hearing loss associated with otitis media with effusion in children. Otolaryngol Head Neck Surg. 2006 Oct;135(4):507-10. [PubMed: 17011408]

63.

Truitt TO, Kosko JR, Nimmons GL, Raisen J, Skovlund SM, Rimell F, Cofer SA. In-office insertion tympanostomy tubes in children using single-pass device. Laryngoscope Investig Otolaryngol. 2021 Apr;6(2):325-331. [PMC free article: PMC8035945] [PubMed: 33869765]

64.

Mills RP. Management of otitis media with effusion in adults. J Laryngol Otol. 2025 Mar 25;:1-6. [PubMed: 40130583]

65.

Miller BJ, Gupta G. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Feb 13, 2023. Adenoidectomy(Archived) [PubMed: 30570973]

66.

Lein A, Altumbabic H, Đešević M, Baumgartner WD, Salkic A, Umihanic S, Ramaš A, Harčinović A, Kosec A, Brkic FF. Association of adenoid hypertrophy and clinical parameters with preoperative polygraphy in pediatric patients undergoing adenoidectomy. Eur Arch Otorhinolaryngol. 2025 Feb;282(2):1075-1084. [PMC free article: PMC11805796] [PubMed: 39565377]

67.

Bluestone CD, Beery QC, Andrus WS. Mechanics of the Eustachian tube as it influences susceptibility to and persistence of middle ear effusions in children. Ann Otol Rhinol Laryngol. 1974 Mar-Apr;83:Suppl 11:27-34. [PubMed: 4819098]

68.

Byars SG, Stearns SC, Boomsma JJ. Association of Long-Term Risk of Respiratory, Allergic, and Infectious Diseases With Removal of Adenoids and Tonsils in Childhood. JAMA Otolaryngol Head Neck Surg. 2018 Jul 01;144(7):594-603. [PMC free article: PMC6145787] [PubMed: 29879264]

69.

Lederberg AR, Schick B, Spencer PE. Language and literacy development of deaf and hard-of-hearing children: successes and challenges. Dev Psychol. 2013 Jan;49(1):15-30. [PubMed: 22845829]

70.

Gan RWC, Overton P, Benton C, Daniel M. Hearing aids for otitis media with effusion: Do children use them? Int J Pediatr Otorhinolaryngol. 2017 Aug;99:117-119. [PubMed: 28688552]

71.

Brough H, Bateman PK, Church P, Thornton SK. The use of hearing devices for children with persistent otitis media with effusion: a scoping review. Int J Audiol. 2025 Sep;64(9):873-881. [PubMed: 40122109]

72.

Alper CM, Teixeira MS, Swarts JD. Eustachian Tube Function in Adults with Ventilation Tubes Inserted for Otitis Media with Effusion. J Int Adv Otol. 2018 Aug;14(2):255-262. [PMC free article: PMC6354449] [PubMed: 30256199]

73.

McLaren O, Toll EC, Easto R, Willis E, Harris S, Rainsbury J. Streamlining grommet pathways for otitis media with effusion and hearing loss in children: our experience. J Laryngol Otol. 2018 Oct;132(10):881-884. [PubMed: 30208983]

74.

Simon F, Haggard M, Rosenfeld RM, Jia H, Peer S, Calmels MN, Couloigner V, Teissier N. International consensus (ICON) on management of otitis media with effusion in children. Eur Ann Otorhinolaryngol Head Neck Dis. 2018 Feb;135(1S):S33-S39. [PubMed: 29398506]

75.

Albrecht P. Antibiotic therapy for an ENT specialist. Otolaryngol Pol. 2018 Sep 11;72(6):1-9. [PubMed: 30647195]

76.

Frost HM, Gerber JS, Hersh AL. Antibiotic Recommendations for Acute Otitis Media and Acute Bacterial Sinusitis. Pediatr Infect Dis J. 2019 Feb;38(2):217. [PubMed: 30640191]

77.

Ahmed A, Kolo E, Aluko A, Abdullahi H, Ajiya A, Bello-Muhammad N, Raji H, Tsiga-Ahmed F. Diagnosis and management of otitis media with effusion in a tertiary hospital in Kano: a best practice implementation project. JBI Database System Rev Implement Rep. 2018 Oct;16(10):2050-2063. [PubMed: 30335043]

78.

Rosenfeld RM, Shin JJ, Schwartz SR, Coggins R, Gagnon L, Hackell JM, Hoelting D, Hunter LL, Kummer AW, Payne SC, Poe DS, Veling M, Vila PM, Walsh SA, Corrigan MD. Clinical Practice Guideline: Otitis Media with Effusion (Update). Otolaryngol Head Neck Surg. 2016 Feb;154(1 Suppl):S1-S41. [PubMed: 26832942]

79.

Jamal A, Alsabea A, Tarakmeh M. Effect of Ear Infections on Hearing Ability: A Narrative Review on the Complications of Otitis Media. Cureus. 2022 Jul;14(7):e27400. [PMC free article: PMC9419542] [PubMed: 36046317]

80.

Mittal R, Lisi CV, Gerring R, Mittal J, Mathee K, Narasimhan G, Azad RK, Yao Q, Grati M, Yan D, Eshraghi AA, Angeli SI, Telischi FF, Liu XZ. Current concepts in the pathogenesis and treatment of chronic suppurative otitis media. J Med Microbiol. 2015 Oct;64(10):1103-1116. [PMC free article: PMC4835974] [PubMed: 26248613]

81.

Maw AR. Development of tympanosclerosis in children with otitis media with effusion and ventilation tubes. J Laryngol Otol. 1991 Aug;105(8):614-7. [PubMed: 1919311]

82.

Dubey SP, Larawin V. Complications of chronic suppurative otitis media and their management. Laryngoscope. 2007 Feb;117(2):264-7. [PubMed: 17277619]

83.

Roberts JE, Rosenfeld RM, Zeisel SA. Otitis media and speech and language: a meta-analysis of prospective studies. Pediatrics. 2004 Mar;113(3 Pt 1):e238-48. [PubMed: 14993583]

84.

Hussain SZM, Hashmi SS, Qayyum A. Ototoxicity of Topical Antibiotic Ear Drops in Chronic Suppurative Otitis Media in Humans: A Review of the Literature. Cureus. 2022 Dec;14(12):e32780. [PMC free article: PMC9855291] [PubMed: 36686080]

85.

Connolly R, Paing A, Reeves T, Joshi D, Kennedy V, Royds J., Guideline Committee. Otitis media with effusion in under 12s: summary of updated NICE guidance. BMJ. 2023 Nov 09;383:2314. [PubMed: 37945047]

Disclosure: Frederick Searight declares no relevant financial relationships with ineligible companies.

Disclosure: Rahulkumar Singh declares no relevant financial relationships with ineligible companies.

Disclosure: Diana Peterson declares no relevant financial relationships with ineligible companies.